Centers for Disease Control and Prevention Continue to Give Guidance on Fungal Meningitis Outbreak across the US
The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA) is investigating a multi-state fungal meningitis outbreak among patients who received contaminated steroid injections. This form of meningitis is not contagious. The investigation also includes fungal infections associated with injections in a peripheral joint space, such as a knee, shoulder or ankle.
The Centers for Medicare & Medicaid Services (CMS) continues to offer guidance for practitioners and patients for the central nervous system (CNS) and/or parameningeal infections and septic arthritis associated with contaminated steroid products produced by the New England Compounding Center (NECC): http://www.cdc.gov/hai/outbreaks/meningitis.html
While the CDC has identified specific states with clinics that have received contaminated product, patients in other states may be impacted and additional information on the outbreak can be found at:
Patients and providers can access the frequently asked questions area of the CDC website to learn more about the resources available.